Prostate cancer Board decisions

The Veteran's claims for service connection for diffuse large B-cell lymphoma, prostate cancer residuals, and squamous cell carcinoma are all granted. The claim for service connection for squamous cell carcinoma is remanded due to the need for a VA medical opinion regarding ionizing radiation exposure.

The Veteran's claims for service connection have been granted for various conditions, including arthritis of the hands, OSA, PFB, prostate cancer, right shoulder arthritis, and degenerative arthritis of the lumbar spine. The remaining issues are being remanded.

The Veteran's service-connected disabilities, including PTSD, prostate cancer residuals, tinnitus, bilateral hearing loss, and erectile dysfunction, have caused him to be unable to obtain or maintain substantially gainful employment. The Board has granted a TDIU rating.

The Board denied service connection for Parkinson's disease and prostate cancer, finding no evidence of exposure to herbicides during service or a link between the conditions and service.

The Board has remanded the Veteran's claims for a neck disability and prostate cancer due to incomplete development of the record, including verification of Reserve service status and additional medical opinions.

The Board has remanded the cases for further development and readjudication due to additional evidence being added to the claims file.

The Board has remanded the claims for throat cancer, lung cancer, and prostate cancer as they are not service-connected due to lack of evidence of ionizing radiation exposure in service.

The Board has remanded the Veteran's claims for service connection for a lumbar spine disorder and prostate cancer (due to herbicide agent exposure) due to insufficient evidence. The Veteran is required to provide authorization for VA to obtain private treatment records, and verification of his in-service herbicide agent exposure must be attempted.

The Veteran's appeal for a restoration of a 100 percent rating for prostate cancer, effective December 1, 2018, and his claim for a higher rating are both remanded due to conflicting evidence regarding the status of his prostate cancer.

The Veteran's prostate cancer residuals have been rated at a maximum of 60 percent since July 13, 2023. The Board denied an increased rating as the evidence does not support a higher rating based on predominant voiding dysfunction.

The Veteran's prostate cancer to include urinary residuals of urethritis epididymitis is rated at 40 percent prior to September 30, 2014, and from October 15, 2019, to May 11, 2023. Since May 11, 2023, the Veteran's prostate cancer to include urinary residuals of urethritis epididymitis is rated at 60 percent.

The Veteran's prostate cancer is presumed to be due to herbicide agent exposure. Service connection for other conditions, including lumbar and cervical spine disorders, right shoulder and left shoulder disorders, bilateral arm and elbow condition, left hand disorder, right foot arthritis, left foot disorder, right toe disorder (except the right great toe), and left toe disorder are granted based on presumptive service connection under the PACT Act. Service connection for other conditions is denied.

The Board has denied service connection for a transient ischemic attack (TIA) as secondary to the service-connected left shoulder adhesive capsulitis, right shoulder status post acromioplasty, and chronic constipation. Service connection for prostate cancer is also denied.

The Board has denied the Veteran's claims for service connection for prostate cancer, diabetes mellitus type II, peripheral neuropathy of the bilateral upper and lower extremities, hypertension, and a thyroid disorder due to lack of evidence supporting herbicide exposure during active duty.

The Veteran's prostate cancer, cutaneous T-cell lymphoma, and Parkinson's disease are granted as due to herbicide exposure during service in Thailand.

The Board denied service connection for diabetes mellitus type II, prostate cancer, and skin cancer (melanoma) as claimed due to exposure to herbicide agents. The evidence did not support the Veteran's claims of in-service herbicide exposure or a link between his current conditions and service.

The Veteran requested to withdraw his appeal for a permanent and total disability rating for prostate cancer, which the Board granted.

The Veteran's claims for migraines, gastrointestinal disorders, prostate cancer, and ischemic heart disease have been dismissed or remanded.,A new claim for service connection of a gastrointestinal disorder has been reopened.

The Board has decided to remand the Veteran's claims for prostate cancer, diabetes mellitus type II, and bilateral lower extremities peripheral neuropathy due to exposure to herbicide agents. The decision is based on insufficient evidence regarding the Veteran's service in recognized herbicide presumptive areas and the need for a VA examination.

The Board has remanded the claims for service connection due to uncertainty about the specific dates of all periods of Active Duty Training and Indefinite Non-Training Duty (ACDUTRA and INACDUTRA) in the Veteran's Reserve service. The claims will be reconsidered after this development.